Brookfield Business Corp (BBUC)vsGenenta Science SpA ADR (GNTA)
BBUC
Brookfield Business Corp
$28.68
+2.36%
INDUSTRIALS · Cap: $5.36B
GNTA
Genenta Science SpA ADR
$0.62
+2.48%
INDUSTRIALS · Cap: $30.38M
Smart Verdict
WallStSmart Research — data-driven comparison
GNTA leads profitability with a 0.0% profit margin vs -0.2%. BBUC earns a higher WallStSmart Score of 55/100 (C-).
BBUC
Buy55
out of 100
Grade: C-
GNTA
Avoid23
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 45.8% YoY
Reasonable price relative to book value
Areas to Watch
ROE of -11.1% — below average capital efficiency
Revenue declined 3.0%
Negative free cash flow — burning cash
Distress zone — elevated risk
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BBUC
The strongest argument for BBUC centers on Price/Book, EPS Growth.
Bull Case : GNTA
The strongest argument for GNTA centers on Price/Book.
Bear Case : BBUC
The primary concerns for BBUC are Return on Equity, Revenue Growth, Free Cash Flow. Debt-to-equity of 8.41 is elevated, increasing financial risk.
Bear Case : GNTA
The primary concerns for GNTA are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
BBUC profiles as a turnaround stock while GNTA is a value play — different risk/reward profiles.
BBUC carries more volatility with a beta of 1.39 — expect wider price swings.
GNTA is growing revenue faster at 0.0% — sustainability is the question.
GNTA generates stronger free cash flow (-2M), providing more financial flexibility.
Bottom Line
BBUC scores higher overall (55/100 vs 23/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brookfield Business Corp
INDUSTRIALS · CONGLOMERATES · USA
Brookfield Business Corporation focuses on healthcare, construction and wastewater services in the United States, Europe, Australia, the United Kingdom, Canada and Brazil. The company is headquartered in New York, New York.
Genenta Science SpA ADR
INDUSTRIALS · CONGLOMERATES · USA
Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.
Visit Website →Compare with Other CONGLOMERATES Stocks
Want to dig deeper into these stocks?